Adverse events264

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 264

Type	Event	Organ system	Group	Affected	At risk
other	Anemia	Blood and lymphatic system disorders	Ruxolitinib Alone First	0	11
other	Anemia	Blood and lymphatic system disorders	Ruxolitinib Plus Paclitaxel First	0	12
other	Anemia	Blood and lymphatic system disorders	Paclitaxel Alone Given As Neoadjuvant Therapy	1	6
other	Anemia	Blood and lymphatic system disorders	Ruxolitinib Plus Paclitaxel Given As Neoadjuvant Therapy	11	17
other	Lymph node pain	Blood and lymphatic system disorders	Ruxolitinib Alone First	0	11
other	Lymph node pain	Blood and lymphatic system disorders	Ruxolitinib Plus Paclitaxel First	0	12
other	Lymph node pain	Blood and lymphatic system disorders	Paclitaxel Alone Given As Neoadjuvant Therapy	1	6
other	Lymph node pain	Blood and lymphatic system disorders	Ruxolitinib Plus Paclitaxel Given As Neoadjuvant Therapy	0	17
other	Dry eye	Eye disorders	Ruxolitinib Alone First	0	11
other	Dry eye	Eye disorders	Ruxolitinib Plus Paclitaxel First	0	12
other	Dry eye	Eye disorders	Paclitaxel Alone Given As Neoadjuvant Therapy	0	6
other	Dry eye	Eye disorders	Ruxolitinib Plus Paclitaxel Given As Neoadjuvant Therapy	1	17
other	Constipation	Gastrointestinal disorders	Ruxolitinib Alone First	0	11
other	Constipation	Gastrointestinal disorders	Ruxolitinib Plus Paclitaxel First	1	12
other	Constipation	Gastrointestinal disorders	Paclitaxel Alone Given As Neoadjuvant Therapy	0	6
other	Constipation	Gastrointestinal disorders	Ruxolitinib Plus Paclitaxel Given As Neoadjuvant Therapy	2	17
other	Diarrhea	Gastrointestinal disorders	Ruxolitinib Alone First	1	11
other	Diarrhea	Gastrointestinal disorders	Ruxolitinib Plus Paclitaxel First	1	12
other	Diarrhea	Gastrointestinal disorders	Paclitaxel Alone Given As Neoadjuvant Therapy	3	6
other	Diarrhea	Gastrointestinal disorders	Ruxolitinib Plus Paclitaxel Given As Neoadjuvant Therapy	3	17

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02876302/events

API reference For AI assistants

Adverse events264

Sources 3

Read this list from software.